Card image cap
EVO+ Visian implantable Collamer lens approved for myopia

The US Food and Drug Administration has approved the EVO/EVO+ Visian implantable Collamer lens for the correction of myopia and myopia with astigmatism, according to a press release from STAAR Surgical. The EVO lenses are implanted in the posterior chamber, behind the iris and in front of the patient’s natural crystalline lens. A preoperative peripheral iridotomy, which was required with earlier versions of the Visian ICL, is not needed with the EVO.

Content by Future Medicine

Disclaimer :
The author(s)' thoughts and opinions in this article are their own and do not necessarily reflect DocMode's viewpoint. The article is in no way created or edited by DocMode.


Supported by Koye Pharmaceuticals

Submit a Comment